Serveur d'exploration SRAS - Checkpoint (Istex)

Index « Titre (en) » - entrée « antiviral »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
antiretroviral < antiviral < antivirals  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000034 (2016) Alex A. Compton [France] ; Nicolas Roy [France] ; Françoise Porrot [France] ; Anne Billet [France] ; Nicoletta Casartelli [France] ; Jacob S. Yount [États-Unis] ; Chen Liang [Canada] ; Olivier Schwartz [France]Natural mutations in IFITM3 modulate post‐translational regulation and toggle antiviral specificity
000265 (2014) Evelien Vanderlinden [Belgique] ; Lieve Naesens [Belgique]Emerging Antiviral Strategies to Interfere with Influenza Virus Entry
000377 (2013) Erik De Clercq [Belgique]Highlights in Antiviral Drug Research: Antivirals at the Horizon
000414 (2013) M. L. Baker [Australie] ; T. Schountz [États-Unis] ; L. Wang [Australie]Antiviral Immune Responses of Bats: A Review
000526 (2012) Kentaro Yoshii [Japon] ; Kanako Moritoh [Japon] ; Noriyo Nagata [Japon] ; Kana Yokozawa [Japon] ; Mizuki Sakai [Japon] ; Nobuya Sasaki [Japon] ; Hiroaki Kariwa [Japon] ; Takashi Agui [Japon] ; Ikuo Takashima [Japon]Susceptibility to flavivirus-specific antiviral response of Oas1b affects the neurovirulence of the Far-Eastern subtype of tick-borne encephalitis virus
000581 (2012) Yuan Liu [République populaire de Chine] ; Qi Yin [République populaire de Chine] ; Yao Yuan [République populaire de Chine] ; Wenyong Yang [République populaire de Chine] ; Chuangui Jiang [République populaire de Chine] ; Canhua Huang [République populaire de Chine]Infectomics Screening for Novel Antiviral Drug Targets
000640 (2012) Howaida I. Abd-Alla [Égypte] ; Nagat S. Abu-Gabal [Arabie saoudite] ; Amal Z. Hassan [Égypte] ; Mounir M. El-Safty [Égypte] ; Nagwa M. M. Shalaby [Arabie saoudite]Antiviral activity of Aloe hijazensis against some haemagglutinating viruses infection and its phytoconstituents
000695 (2011) Erik De Clercq [Belgique]The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures
000819 (2011) Priya S. Shah [États-Unis] ; David V. Schaffer [États-Unis]Antiviral RNAi: Translating Science Towards Therapeutic Success
000E30 (2009) Erik De Clercq [Belgique]Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives
001098 (2008) Samson S. Y. Wong [Hong Kong] ; Kwok-Yung Yuen [Hong Kong]Antiviral therapy for respiratory tract infections
001121 (2008) I. V. Ukrainets [Ukraine] ; N. L. Bereznyakova [Ukraine] ; I. A. Turaibei [Ukraine, Russie]4-Hydroxy-2-quinolones 139. Synthesis, structure, and antiviral activity of N-R-amides of 2-hydroxy-4-oxo-4H-pyrido[1,2- a ]pyrimidine-3-carboxylic acids
001432 (2007) Murray E. Alexander [Canada] ; Seyed M. Moghadas [Canada] ; Gergely Röst [Hongrie, Canada] ; Jianhong Wu [Canada]A Delay Differential Model for Pandemic Influenza with Antiviral Treatment
001533 (2006) Yuki Naito [Japon] ; Kumiko Ui-Tei [Japon] ; Toru Nishikawa [Japon] ; Yutaka Takebe [Japon] ; Kaoru Saigo [Japon]siVirus: web-based antiviral siRNA design software for highly divergent viral sequences
001782 (2006) Lars Hangartner [Suisse] ; Rolf M. Zinkernagel [Suisse] ; Hans Hengartner [Suisse]Antiviral antibody responses: the two extremes of a wide spectrum
001783 (2006) Erik De Clercq [Belgique]Antiviral agents active against influenza A viruses
001D60 (2004) P D GriffithsShould vaccines and antiviral therapy for influenza now be deployed strategically?
001F98 (2004) Ira M. Longini ; M. Elizabeth Halloran ; Azhar Nizam ; Yang YangContaining Pandemic Influenza with Antiviral Agents
002056 (2004) W C Yu [République populaire de Chine] ; D S C. Hui [République populaire de Chine] ; M. Chan-Yeung [République populaire de Chine]Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS)
002426 (1995) John Saunders [Royaume-Uni] ; Janet M. Cameron [Royaume-Uni]Recent developments in the design of antiviral agents

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "antiviral" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "antiviral" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    antiviral
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021